Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Lymphoma, T-Cell, Peripheral × carfilzomib × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 30 Recurrence 6 Neoplasms, Plasma Cell 4 Small Cell Lung Carcinoma 3 Lymphoma 3 Ovarian Neoplasms 2 Disease 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia 1 Kidney Neoplasms 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Esophageal Neoplasms 1 Amyloidosis 1

Interventions

romidepsin 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5 Vincristine 3 Prednisone 3 Lenalidomide 3 Gemcitabine 3 Doxorubicin 3 Cyclophosphamide 3 Azacitidine 3 ixazomib 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Dexamethasone 2 Cyclosporine 2 Bortezomib 2 10-propargyl-10-deazaaminopterin 2 venetoclax 1 tislelizumab 1 tazemetostat 1 relatlimab 1 pomalidomide 1 navitoclax 1 mogamulizumab 1 gemcitabine-oxaliplatin regimen 1 daratumumab 1 copanlisib 1 carfilzomib 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03141203 2022-05-18

RomiCar

University of Birmingham

Phase 1/2 Completed

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡